Results 11 to 20 of about 82,320 (302)

Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines [PDF]

open access: yesVaccines, 2022
Following the introduction of live-attenuated rotavirus vaccines in many countries, a notable reduction in deaths and hospitalisations associated with diarrhoea in children
Prisca Benedicto-Matambo   +11 more
doaj   +3 more sources

Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses

open access: yesViruses
Single-dose, immunogenic DNA (iDNA) vaccines coding for whole live-attenuated viruses are reviewed. This platform, sometimes called immunization DNA, has been used for vaccine development for flavi- and alphaviruses.
Peter Pushko   +3 more
doaj   +2 more sources

Natural Attenuated Vaccines for Pasteurella multocida

open access: yesBiology
Pasteurella multocida is capable of infecting various animal species, causing hemorrhagic septicemia or infectious pneumonia, and it is widely prevalent and pathogenic worldwide.
Qingyuan Xu   +3 more
doaj   +2 more sources

LIVE ATTENUATED VACCINES FOR THE IMMUNOPROPHYLAXIS

open access: yesИнфекция и иммунитет, 2017
The review focuses on the history of the production of live antiviral vaccines and their use for the prevention of infectious diseases. It was noted that before the beginning of the 20th century, only three live vaccines were developed and put into ...
O. A. Shamsutdinova
doaj   +3 more sources

Live-Attenuated Vaccines in Pediatric Solid Organ Transplant

open access: yesVaccines
Measles, mumps, rubella (MMR), and varicella incidence rates have increased due to the delayed vaccination schedules of children secondary to the COVID-19 pandemic. Decreased herd immunity creates a risk for immunocompetent children and immunocompromised
Christopher Hartley   +3 more
doaj   +2 more sources

Live Attenuated Vaccines against Tuberculosis: Targeting the Disruption of Genes Encoding the Secretory Proteins of Mycobacteria

open access: yesVaccines
Tuberculosis (TB), a chronic infectious disease affecting humans, causes over 1.3 million deaths per year throughout the world. The current preventive vaccine BCG provides protection against childhood TB, but it fails to protect against pulmonary TB ...
Raja Veerapandian   +3 more
doaj   +2 more sources

A Chymotrypsin-Dependent Live-Attenuated Influenza Vaccine Provides Protective Immunity against Homologous and Heterologous Viruses

open access: yesVaccines
Influenza virus is one of the main pathogens causing respiratory diseases in humans. Vaccines are the most effective ways to prevent viral diseases. However, the limited protective efficacy of current influenza vaccines highlights the importance of novel,
Peiqing He   +8 more
doaj   +2 more sources

Research Progress on Varicella-Zoster Virus Vaccines

open access: yesVaccines
Varicella-zoster virus (VZV) poses significant public health challenges as the etiological agent of varicella (chickenpox) and herpes zoster (HZ), given its high transmissibility and potential for severe complications.
Hongjing Liu   +11 more
doaj   +2 more sources

Radiation-attenuated schistosome vaccination--a brief historical perspective. [PDF]

open access: yes, 2009
The high level of protection which can be induced by vaccination of a range of hosts, from rodents to primates, with live radiation-attenuated schistosome larvae offers great promise for development of a human schistosome vaccine.
Bickle, QD, Q. D. BICKLE
core   +1 more source

Development of Streptococcus pneumoniae Vaccines Using Live Vectors [PDF]

open access: yes, 2015
: Streptococcus pneumoniae still causes severe morbidity and mortality worldwide, especially in young children and the elderly. Much effort has been dedicated to developing protein-based universal vaccines to conquer the current shortcomings of capsular ...

core   +1 more source

Home - About - Disclaimer - Privacy